• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, June 26, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Georgetown University Medical Center selects Nora Volkow for Highest Honor

Bioengineer by Bioengineer
November 13, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: National Institute on Drug Abuse (NIDA)

WASHINGTON (November 13, 2018) — Georgetown University Medical Center (GUMC) will present Nora Volkow, MD, director of the National Institute on Drug Abuse, a part of the National Institutes of Health, with its highest honor, the Cura Personalis Award, at a ceremony on Tuesday, Nov. 13 at 4:00 p.m.

"The tradition of bestowing of the Cura Personalis Award is a highlight of our annual GUMC Convocation as we recognize a health professional who has made outstanding contributions to human health guided by compassion and service," says Edward B. Healton, MD, MPH, Executive Vice President for Health Sciences at Georgetown University.

The Catholic, Jesuit principle of cura personalis means care of the whole person. It suggests individualized attention to the needs of others, distinct respect for unique circumstances and concerns, and an appropriate appreciation for singular gifts and insights.

"This is our founding principle and one that has been embraced by Dr. Volkow-demonstrated through her professional role as an institute director and through her addiction research," Healton adds.

For more than 15 years, Volkow has led the NIDA's research effort to address the health aspects of drug abuse and addiction. Volkow's own work has been instrumental in demonstrating that drug addiction is a disease of the human brain. As a research psychiatrist and scientist, Volkow pioneered the use of brain imaging to investigate the toxic effects and addictive properties of abusable drugs. Her studies have documented changes in the dopamine system affecting, among others, the functions of frontal brain regions involved with motivation, drive, and pleasure in addiction. She has also made important contributions to the neurobiology of obesity, ADHD, and aging.

Volkow earned her medical degree from the National University of Mexico in Mexico City. Her completed her psychiatric residency with distinction at New York University. Before assuming her responsibilities at NIDA, she spent most of her professional career at the Department of Energy's Brookhaven National Laboratory in New York, where she held several leadership positions including Director of Nuclear Medicine, Chairman of the Medical Department, and Associate Director for Life Sciences. In addition, Volkow was a Professor in the Department of Psychiatry and Associate Dean of the Medical School at the State University of New York-Stony Brook.

Volkow is a member of the National Academy of Sciences. She has received the International Prize from the French Institute of Health and Medical Research for her pioneering work in brain imaging and addiction science, and was awarded the Carnegie Prize in Mind and Brain Sciences from Carnegie Mellon University.

###

Volkow will receive the Cura Personalis medal during the 11th Annual GUMC Convocation on Tuesday, Nov. 13th during the awards ceremony which begins at 4:00 p.m. Earlier in the day, beginning at 10:00 a.m., Volkow will join the Convocation Colloquium to explore issues of addiction and the opioid crisis.

Both activities are held in the Research Building auditorium on the GUMC campus.

About Georgetown University Medical Center

Georgetown University Medical Center (GUMC) is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis — or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes of Health. Connect with GUMC on Facebook (Facebook.com/GUMCUpdate), Twitter (@gumedcenter) and Instagram (@GeorgetownMedicine).

Media Contact

Karen Teber
[email protected]
@Gumedcenter

Home Page

Share12Tweet8Share2ShareShareShare2

Related Posts

Tracking Lanthanide-Labeled Microplastics in Plants

June 25, 2026

Neural Design Enables Zero-Shot Drug-Binding Proteins

June 25, 2026

Genomic Insights into Human Skin Fungi Diversity

June 25, 2026

Chiral Laser Gyroscopes Surpass Lock-In Limit

June 25, 2026
Please login to join discussion

POPULAR NEWS

  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    92 shares
    Share 36 Tweet 23
  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tracking Lanthanide-Labeled Microplastics in Plants

POSTECH Researchers Slash Cost of Reconstituted Cell-Free Systems by 95%

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.